Opioid receptors, traditionally studied for their roles in analgesia and addiction, constitute a neuropeptide-based signalling axis that interfaces tightly with the circuits governing stress and mood, and thus belong logically within the “neuropeptide stress” domain of depression neurobiology [213]. The gene discussed is NPS; the disease is major depressive disorder.